Literature DB >> 15009726

An assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype.

Chandra Gooptu Bertram1, Rupert M Gaut, Jennifer H Barrett, Juliette Randerson-Moor, Linda Whitaker, Faye Turner, Veronique Bataille, Isabel dos Santos Silva, Anthony J Swerdlow, D Timothy Bishop, Julia A Newton Bishop.   

Abstract

Inheritance of the T allele in exon 7 (position 18067) of the DNA repair gene XRCC3 has been reported to be associated with susceptibility to melanoma in a study from Oxford. We report a study in which an attempt was made to confirm this association in a similar population. The most potent risk factor for melanoma in the general population is a phenotype characterized by the presence of multiple melanocytic nevi: the atypical mole syndrome. Our hypothesis is that the atypical mole syndrome may be a marker of genetic susceptibility to melanoma. We have therefore investigated whether the XRCC3 polymorphism influences the nevus phenotype. The XRCC3 genotype was investigated using PCR in a general-practice-based sample of 565 women and 475 patients from a cohort enriched for the atypical mole syndrome, of whom 140 had had melanoma. Allele frequencies were the same in the healthy women, the melanoma cases from this study, and the melanoma cases reported in the Oxford study, but were different from those in the Oxford control group. We found no evidence therefore that the T allele of this XRCC3 polymorphism is indicative of susceptibility to melanoma. There was a marginal relationship with nevus phenotype, but this was no longer statistically significant in multivariate analysis. The previous association between XRCC3 and melanoma may be a result of the choice of control group and we emphasize the need for appropriate choice of controls.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009726     DOI: 10.1046/j.0022-202X.2003.12541.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  XRCC3 T241M polymorphism and melanoma skin cancer risk: A meta-analysis.

Authors:  Jinghua Fan; Yuhua Fan; Xiaoxiao Kang; Limin Zhao
Journal:  Oncol Lett       Date:  2015-03-16       Impact factor: 2.967

Review 2.  cAMP-mediated regulation of melanocyte genomic instability: A melanoma-preventive strategy.

Authors:  Nathaniel C Holcomb; Robert-Marlo Bautista; Stuart G Jarrett; Katharine M Carter; Madeline Krentz Gober; John A D'Orazio
Journal:  Adv Protein Chem Struct Biol       Date:  2018-12-05       Impact factor: 3.507

3.  Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data.

Authors:  Juliette A Randerson-Moor; John C Taylor; Faye Elliott; Yu-Mei Chang; Samantha Beswick; Kairen Kukalizch; Paul Affleck; Susan Leake; Sue Haynes; Birute Karpavicius; Jerry Marsden; Edwina Gerry; Linda Bale; Chandra Bertram; Helen Field; Julian H Barth; Isabel Dos Santos Silva; Anthony Swerdlow; Peter A Kanetsky; Jennifer H Barrett; D Timothy Bishop; Julia A Newton Bishop
Journal:  Eur J Cancer       Date:  2009-07-15       Impact factor: 9.162

4.  XRCC3 C18067T polymorphism contributes a decreased risk to both basal cell carcinoma and squamous cell carcinoma: evidence from a meta-analysis.

Authors:  Xu Chen; Zhe Wang; Yulan Yan; Ping Li; Zheng Yang; Lingyan Qin; Wuning Mo
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.